Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and greatly reduce the risk of systemic side effects inherent in current therapeutic approaches. Promedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.

Weihai Newpu Biotechnology Co., Ltd., established on 2014-07-07, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical equipment rental(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Nanjing Liding Biotechnology Co., Ltd., established on 2017-06-20, The scope of business includes technical consultation on biological products,technology development,technology transfer,Technical Services,Sales;Medical Technology Consulting,technology development,technology transfer,Technical Services;experiment equipment,Technology research and development of instruments and meters,Sales;medical instruments,experiment apparatus,Rental of office supplies and accessories,repair,research and development,Sales;laboratory consumables,Electronic equipment,Sales of machinery and equipment;Self-operated and agent import and export business of various commodities and technologies.pharmaceutical production;Production of Class I Medical Devices;Manufacturing of Specialty Chemical Products;Inspection and testing service;Drug Manufacturing;Animal Clinic;Medical Research and Experimental Development;Entry-Exit Quarantine Processing;Quality and safety inspection of agricultural products;Technology guidance;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

PREB engages in the research, development, production, sales, and service of in vitro diagnostic products. Their products cover the protein detection platform WP series, the POCT platform PA series, the biochemical detection platform PB series, and other detection platforms.

Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. From Uganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.

Wuhan Kangshengda Medical Laboratory Co., Ltd. is a private company headquartered in Wuhan, China. The firm operates medical laboratories. It was founded in 2003. Zan Bing Tu is currently the CEO of the company.

Beijing Kangsi Runye Biotechnology Co., Ltd., established on 2004-04-14, Business scope includes bioengineering technology,development of computer technology,consult,transfer;Technical consultation for self-produced products;Sell ​​self-produced products;Import and export,Agent import and export;Production of Class I medical devices;SalesIkind,IIclass of medical devices;compound,packIIclass of medical devices:II-6840In vitro diagnostic reagents;production of medical devicesIIkind:II-6840-3Immunoassay system;Production of Class III medical devices;Sales of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class III medical devices,compound,packIIclass of medical devices:II-6840In vitro diagnostic reagents;production of medical devicesIIkind:II-6840-3Immunoassay system,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Guangzhou Fuda Cancer Hospital is a tertiary specialized cancer hospital which is affiliated with the Health Department of Guangdong Province in China. It was designated a national key clinical (cancer) hospital by the National Health and Family Planning Commission in 2011. The same year, Guangzhou Fuda Cancer Hospital was honored with National Trustworthy Private Hospital by the National Institute of Hospital Administration. In 2012, China Hospital Association rated Guangzhou Fuda Cancer Hospital as China Public Confidence Model Hospital. It was accredited by JCI in 2014.

Chongqing Bai Ruide Biotechnology Co., Ltd., established on 2014-10-09, Business scope includes general items:Production of Medical Devices,Processing and sales,Production of in vitro diagnostic reagents,Processing and sales;Sales:electronic product(Does not include electronic publications),Fitness Equipment,Daily necessities,Chemical Products(Free of hazardous chemicals and precursor chemicals),cosmetic;Agricultural Technology Development,technical consulting,Technical Services;Healthy food,electronic product(Does not include electronic publications)technology development;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guizhou Shengshikang Biotechnology Co., Ltd., established on 2018-09-07, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;R&D of industrial enzyme preparations;Medical Research and Experimental Development;Retailing of computer software, hardware and auxiliary equipment;Instrument sales;Production of Class I Medical Devices;Sales of Class I Medical Devices;Production of Class II Medical Devices;Sales of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;production of agricultural products,Sales,processing,transportation,Storage and other related services;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments))

Nanjing Shenji Pharmaceutical Technology Co., Ltd., established on 2018-08-02, Business scope includes medical technology research and development,technical consulting,Technical Services,technology transfer;Biotechnology R&D,technical consulting,Technical Services,technology transfer;experiment apparatus,Medical device research and development,Production,Sales;laboratory consumables,Chemical Products(Does not contain hazardous chemicals),Instrumentation,Electronic equipment,Machinery sales;Self-operated and agent import and export business of various commodities(Except for commodities and technologies that are restricted or prohibited by the state for import and export);Nutrition and Health Consulting Services;health service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Veterinary drug business;Veterinary drug production;Animal Clinic(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Shenzhen Comen Medical Instruments Co. Ltd. is a Chinese private company that manufactures and distributes medical equipment.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. engages in the manufacture, sale, research and development of household products and medical equipment. It also develops, manufactures, markets, and sells electro-medical equipment in the patient monitoring, laboratory instrument, and medical ultrasound fields. The company was founded by Hang Xu on January 25, 1991 and is headquartered in Shenzhen, China.

Shanghai Upper Bio-Tech Pharma Co., Ltd. is a company headquartered in Shanghai, China, that develops and manufactures medical kits. The firm was founded in 1994. Fu Gang Li is the current CEO of the company.

Chengdu Pulitai Biotechnology Co., Ltd., established on 2015-04-07, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Veterinary drug production;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:software development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;Mechanical equipment research and development;Machinery sales;Manufacturing of plastic products;Sales of plastic products;Manufacturing of medical packaging materials;Non-residential real estate leases;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Nanjing Liding Medical Technology Co., Ltd., established on 2019-05-16, Business scope includes licensed projects:pharmaceutical production;Production of Class II Medical Devices;Production of Class III Medical Devices;Drug Manufacturing;Inspection and testing service;Animal Clinic;Entry-Exit Quarantine Processing;Quality and safety inspection of agricultural products(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of experimental analysis instruments;Experimental analysis instrument sales;Machinery sales;Machinery and Equipment Leasing;Mechanical equipment research and development;Import and export;Technology Import and Export;Import and export agency;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;R&D of industrial enzyme preparations;R&D and application of cell technology;Biochemical product technology research and development;Synthetic Materials Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Beijing Keyue Zhongkai Biotechnology Co., Ltd., established on 2007-06-07, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of bio-based materials;Sales of bio-based materials;Research and development of bio-based material polymerization technology;Biochemical product technology research and development;R&D of industrial enzyme preparations;Manufacture of new membrane materials;Medical Research and Experimental Development;Natural science research and experimental development;Technology Import and Export;Import and export;Chemical product sales(No licensed chemical products).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Femta Pharmaceuticals, Inc. develops antibody therapeutics. The company was founded in June 2008 and is headquartered in San Diego, CA.